Your browser doesn't support javascript.
loading
Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors.
Serrano, César; Rothschild, Sara; Villacampa, Guillermo; Heinrich, Michael C; George, Suzanne; Blay, Jean-Yves; Sicklick, Jason K; Schwartz, Gary K; Rastogi, Sameer; Jones, Robin L; Rutkowski, Piotr; Somaiah, Neeta; Navarro, Víctor; Evans, Denisse; Trent, Jonathan C.
Afiliación
  • Serrano C; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. cserrano@vhio.net.
  • Rothschild S; Sarcoma Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. cserrano@vhio.net.
  • Villacampa G; The Life Raft Group, Wayne, NJ, USA.
  • Heinrich MC; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • George S; The Institute of Cancer Research, London, UK.
  • Blay JY; Portland VA Health Care System and Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Sicklick JK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Schwartz GK; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Rastogi S; Université Claude Bernard, Lyon, France.
  • Jones RL; Department of Surgery, Division of Surgical Oncology, University of California San Diego, La Jolla, CA, USA.
  • Rutkowski P; Department of Pharmacology, University of California San Diego, San Diego, CA, USA.
  • Somaiah N; Case Comprehensive Cancer Center in Cleveland, Cleveland, OH, USA.
  • Navarro V; Department of Medical Oncology, All India Institute of Medical Science (AIIMS), New Delhi, India.
  • Evans D; Division of Clinical Studies, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, UK.
  • Trent JC; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Nat Med ; 29(11): 2689-2692, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37828359

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / Neoplasias Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / Neoplasias Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: España
...